Tony joined the Metalysis Board in October 2014. He brings a wealth of experience gained in fast growth technology companies. Most recently Tony was Group CFO at Brady plc, an AIM listed metals and commodities software vendor, where he contributed to significant international growth over six years, led six acquisitions and delivered two share placings.
Previously, Tony was CFO at Gemini Genomics plc where he led their successful $450m Nasdaq IPO, raising $96m of new cash, then their subsequent merger with Sequenom, Finance Director at i2 Limited which enjoyed considerable growth leading to a merger with Choicepoint, realising some $100m in cash for shareholders.
Tony also established his own company, Consilium Financial Limited, undertaking various financial management projects for technology companies, including the execution of acquisitions, driving change management and business planning initiatives.
Tony holds a BSc in Accountancy from the University of East Anglia, an MBA from Heriot-Watt University, Edinburgh, an ACA and is a Chartered Accountant, having trained with KPMG.